Bextra Teaching 31

Charting language
Instructed in new medication Bextra to manage osteoarthritis. In addition. warned of possible S/E such as dizziness, headache, cerebrovascular disorder, peripheral edema, hypertension, angina pectoris, arrhythmia, heart failure, aneurysm, sinusitis, abdominal fullness, abdominal pain, diarrhea, dyspepsia, flatulence, nausea, renal impairment, thrombocytopenia, leukopenia, anemia, hepatitis, hyperglycemia, hypercholesterolemia, hyperkalemia, hyperlipidemia, hyperuricemia, hypocalcemia, hypokalemia, increased or decreased weight, back pain, myalgia, upper respiratory tract infection, bronchospasm, rash, flu-like syndrome, accidental injury.

Reviewed November 2017

Reviewed for general reference only. Adapt to your patient, agency policy, and scope of practice.